C12N 2760/16121
Viruses as such
Official title: Viruses as such, e.g. new isolates, mutants or their genomic sequences
C12N2760/16121 (Viruses as such) appears on 158 US grants and 235 published applications in this corpus.
Search patents in C12N- Granted patents
- 158
- Published applications
- 235
- Assignees
- 119
- Inventors
- 348
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2001 | 1 | 0 |
| 2002 | 1 | 0 |
| 2003 | 2 | 3 |
| 2004 | 0 | 2 |
| 2005 | 2 | 4 |
| 2006 | 1 | 4 |
| 2007 | 0 | 1 |
| 2008 | 0 | 3 |
| 2009 | 8 | 9 |
| 2010 | 1 | 7 |
| 2011 | 4 | 5 |
| 2012 | 4 | 6 |
| 2013 | 3 | 12 |
| 2014 | 9 | 11 |
| 2015 | 11 | 7 |
| 2016 | 12 | 21 |
| 2017 | 8 | 15 |
| 2018 | 17 | 16 |
| 2019 | 12 | 11 |
| 2020 | 9 | 16 |
| 2021 | 10 | 16 |
| 2022 | 10 | 19 |
| 2023 | 10 | 12 |
| 2024 | 9 | 17 |
| 2025 | 7 | 8 |
| 2026 | 7 | 10 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Construction and application of recombinant H5N8 subtype avian influenza virus carrying mapple fluorescence reporter gene16 Jun 2026US 12,655,396 B2South China Agricultural University
- Recombinant non-structural protein 1, recombinant influenza virus and immunological composition including the same, and method of treating or preventing disease or condition caused by or associated with influenza virus26 May 2026US 12,636,358 B2National Cheng Kung University
- Nucleic acid molecules and dual-functional peptides having antiviral activity and delivery activity, compositions and methods thereof12 May 2026US 12,624,368 B2The University of Hong Kong
- Influenza virus backbone21 Apr 2026US 12,606,804 B2FluGen, Inc.
- Method of labelling viral particles comprising anionic lipids with fluorescently-labelled negatively-charged polynucleotides in the presence of polyvalent cations21 Apr 2026US 12,607,635 B2Oxford University Innovation Limited
- Influenza b virus mutants and uses therefor10 Sep 2026US 2026/0263586 A1FluGen, Inc.
- Mosaic influenza virus hemagglutinin polypeptides and uses thereof30 Jul 2026US 2026/0216314 A1Icahn School of Medicine at Mount Sinai
- Influenza virus backbone2 Jul 2026US 2026/0185059 A1FluGen, Inc.
- Immunogenic compositions against influenza11 Jun 2026US 2026/0158128 A1FluGen, Inc.
- Low-sugar influenza vaccine and methods thereof11 Jun 2026US 2026/0158130 A1
Most cited
By later US patents
- Method for generating influenza viruses and vaccines82US 7,037,707 B2St. Jude Children?S Research Hospital · 2006
- Interferon inducing genetically engineered attenuated viruses39US 6,468,544 B1Mount Sinai School of Medicine of the City University of New York · 2002
- Methods and interferon deficient substrates for the propagation of viruses37US 6,852,522 B1Mount Sinai School of Medicine of New York University · 2005
- Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals35US 6,669,943 B1Mount Sinai School of Medicine of New York University · 2003
- Methods and interferon deficient substrates for the propagation of viruses34US 6,573,079 B1Mount Sinai School of Medicine of New York University · 2003